We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effectiveness of β-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?
- Authors
Dobre, Daniela; DeJongste, Mike J. L.; Lucas, Carolien; Cleuren, Ger; van Veldhuisen, Dirk J.; Ranchor, Adelita V.; Haaijer-Ruskamp, Flora
- Abstract
Aims The effects of β-blockers in daily practice patients with advanced chronic heart failure (CHF) and a broad range of ejection fraction (EF) are not well established. We aimed to assess, first , the association between β-blocker prescription at discharge and mortality in a cohort of patients with advanced CHF, and second , whether this association is modified by the age of the patient. Methods Patients diagnosed with advanced CHF ( n = 625) were prospectively followed after discharge from the Cardiology Department . The mean age was 76 years, 53% male, mean EF 42 ± 16%. Overall, 308 (49%) patients had a β-blocker prescribed at discharge, 140 (22%) low-dose and 168 (27%) high-dose therapy. We used multivariate Cox analysis to assess the association between β-blocker use at discharge and mortality. Results After a mean follow-up of 22 months, 117 (27%) patients died. Prescription of a β-blocker was associated with a 45% relative risk reduction (hazard ratio 0.55, 95% confidence interval 0.39, 0.78). The relative risk reduction was similar with low and high doses of β-blockers (42% and 49%). However, the relative risk reduction was higher in younger than in older patients ( P = 0.006). In patients ≤75 years old prescription of a β-blocker was associated with 71% risk reduction, whereas in patients >75 years old it was associated with 21% risk reduction. Conclusions In this daily practice cohort of patients with advanced CHF, prescription of a β-blocker was associated with significant mortality reduction. However, the beneficial effects of β-blockers appear to be greater in younger patients.
- Subjects
MORTALITY; HEART diseases; HEART failure; CARDIAC arrest; CONFIDENCE intervals; STATISTICAL hypothesis testing
- Publication
British Journal of Clinical Pharmacology, 2007, Vol 63, Issue 3, p356
- ISSN
0306-5251
- Publication type
Article
- DOI
10.1111/j.1365-2125.2006.02769.x